4H-4a,7-Methanooxazirino[3,2-i][2,1]benzisothiazole,8,8-dichlorotetrahydro-9,9-dimethyl-, 3,3-dioxide, (2R,4aS,7S,8aR)-
- 中文别名：(+)-8,8-二氯樟脑磺哑嗪
- 中文释义：(+)-3,3-二氯-2,N-环氧-外型-10,2-莰烷磺内酰胺;(+)-8,8-二氯樟脑磺哑嗪
- 英文别名：(+)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine;
()-3,3-Dichloro-2,N-epoxy-exo-10,2-bornanesultam;
[2R-(2|A,4a|A,7|A,8aR*)]-8,8-Dichlorotetrahydro-9,9-dimethyl-4H-4a,7-methanooxazirino[3,2-i][2,1]benzisothiazole 3,3-Dioxide;
(+)-((8,8-Dichlorocamphoryl)sulfonyl)oxaziridine
- CAS No.：127184-05-8
- 分子式：C10H13Cl2NO3S
- 分子量：298.19
- 精确分子量：296.99900
- PSA：58.06000
- InChI：The Key: HAMBQYFZDBYWHU-JYMQCGNZSA-N
- 分子结构式：
物化性质
- 密度：
- 1.687 g/cm3
- 熔点：
- 181-186ºC
- 沸点：
- 390.471ºC at 760 mmHg
- 闪点：
- 189.95ºC
- 折射率：
- 1.648
安全信息
- 密度：
- 1.687 g/cm3
- 熔点：
- 181-186ºC
- 沸点：
- 390.471ºC at 760 mmHg
- 闪点：
- 189.95ºC
- 折射率：
- 1.648
MSDS
| Name: | (+)-[(8 8-Dichlorocamphoryl)sulfonyl]oxazi ridine Material Safety Data Sheet |
| Synonym: | (+)-3,3-Dichloro-2,N-epoxy-exo-10,2-bornanesulta |
| CAS: | 127184-05-8 |
Section 1 - Chemical Product MSDS Name:(+)-[(8 8-Dichlorocamphoryl)sulfonyl]oxazi ridine Material Safety Data Sheet
Synonym:(+)-3,3-Dichloro-2,N-epoxy-exo-10,2-bornanesulta
Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
| CAS# | Chemical Name | content | EINECS# |
| 127184-05-8 | (+)-[(8,8-Dichlorocamphoryl)sulfonyl]o | | unlisted |
Hazard Symbols: Not available.
Risk Phrases:
Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
Not available.
Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower lids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
In case of fire use water spray, dry chemical, carbon dioxide, or chemical foam.
Autoignition Temperature: Not available.
Flash Point: Not available.
NFPA Rating: Not published.
Explosion Limits, Lower: Not available.
Upper: Not available.
Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.
Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Do not store in direct sunlight. Store in a tightly closed container. Keep under a nitrogen blanket.
Refrigerator (approx 4C).
Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29CFR 1910.134. Always use a NIOSH-approved respirator when necessary.
Section 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Solid
Appearance: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Vapor Density: Not available.
Evaporation Rate: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 180 - 181 deg C
Decomposition Temperature: Not available.
Solubility: Not available.
Specific Gravity/Density: Not available.
Molecular Formula: C10H13Cl2NO3S
Molecular Weight: 298.18
Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported
Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 127184-05-8 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(+)-[(8,8-Dichlorocamphoryl)sulfonyl]oxaziridine - Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
See actual entry in RTECS for complete information.
Section 12 - ECOLOGICAL INFORMATION
For further information, contact Fisher Scientific.
Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.
Section 14 - TRANSPORT INFORMATION
CDG/CPL
IMO
Not regulated as a hazardous material.
IATA
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
Canadian TDG
No information available.
Section 15 - REGULATORY INFORMATION
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 127184-05-8:
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
WHMIS: Not available.
CAS# 127184-05-8 is not listed on Canada's Ingredient Disclosure List.
Exposure Limits
US FEDERAL
TSCA
CAS# 127184-05-8 is not listed on the TSCA inventory.
It is for research and development use only.
SECTION 16 - ADDITIONAL INFORMATION
N/A
